| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.28e-06 | 26 | 207 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PSMC2 DQX1 ABCC8 NAV3 KIF5B ABCC2 RAD51D ATP8B3 RHOBTB3 CHD7 ATP9A FANCM POLQ SNRNP200 | 2.17e-04 | 441 | 207 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | PSMC2 DNAH14 UBA7 DQX1 ABCC8 NAV3 KIF5B ABCC2 RAD51D ATP8B3 RHOBTB3 CHD7 ATP9A FANCM POLQ SNRNP200 ACSL5 | 2.37e-04 | 614 | 207 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 3.19e-04 | 3 | 207 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.67e-04 | 14 | 207 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | transporter activity | KCNH8 GJB4 SLC35E2B RYR2 SLC38A2 CLDN17 ABCC8 SCN1A SCN2A SCN8A OSBPL10 SLC25A53 SLC38A11 GJB7 ABCC2 SLC9A6 MCOLN2 ATP8B3 GRIA3 GRIA4 ATP9A SLC17A5 PRELID3A SLC12A4 SLC7A5 SLC39A14 SLC2A12 | 3.87e-04 | 1289 | 207 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | smoothened binding | 6.33e-04 | 4 | 207 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 6.33e-04 | 4 | 207 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 6.33e-04 | 4 | 207 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 6.71e-04 | 17 | 207 | 3 | GO:0005545 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.09e-05 | 105 | 207 | 8 | GO:1901879 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP1B TRIO MAP2 INPP4A SPTAN1 SPTB FAAH SEMA3A NRXN3 SCN2A SCN8A WDR1 CPSF2 SLC9A6 AMPH GRIA3 GRIA4 TAMALIN SLC17A5 CD47 MARK2 | 9.86e-05 | 817 | 213 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | sodium channel complex | 2.04e-04 | 29 | 213 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | axon initial segment | 2.04e-04 | 29 | 213 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | main axon | 3.00e-04 | 89 | 213 | 6 | GO:0044304 | |
| MousePheno | low mean erythrocyte cell number | 1.01e-05 | 12 | 172 | 4 | MP:0002594 | |
| Domain | Spectrin | 1.45e-07 | 23 | 206 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 6.43e-07 | 29 | 206 | 6 | IPR002017 | |
| Domain | - | IFT172 COPB2 BIRC6 WDR43 SEMA3A WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 ARHGEF10L NBAS STRAP WDR12 | 9.45e-07 | 333 | 206 | 16 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | IFT172 COPB2 BIRC6 WDR43 SEMA3A WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 ARHGEF10L NBAS STRAP WDR12 | 1.02e-06 | 335 | 206 | 16 | IPR015943 |
| Domain | SPEC | 1.19e-06 | 32 | 206 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.19e-06 | 32 | 206 | 6 | IPR018159 | |
| Domain | G-protein_beta_WD-40_rep | 4.45e-06 | 85 | 206 | 8 | IPR020472 | |
| Domain | WD40_repeat_dom | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X UBR4 WDR70 ARHGEF10L STRAP WDR12 | 5.74e-06 | 297 | 206 | 14 | IPR017986 |
| Domain | WD_REPEATS_1 | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 NBAS STRAP WDR12 | 1.36e-05 | 278 | 206 | 13 | PS00678 |
| Domain | WD_REPEATS_2 | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 NBAS STRAP WDR12 | 1.41e-05 | 279 | 206 | 13 | PS50082 |
| Domain | WD_REPEATS_REGION | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 NBAS STRAP WDR12 | 1.41e-05 | 279 | 206 | 13 | PS50294 |
| Domain | Na_trans_cytopl | 2.58e-05 | 6 | 206 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 2.58e-05 | 6 | 206 | 3 | IPR024583 | |
| Domain | WD40 | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 STRAP WDR12 | 3.20e-05 | 259 | 206 | 12 | PF00400 |
| Domain | WD40 | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 STRAP WDR12 | 4.46e-05 | 268 | 206 | 12 | SM00320 |
| Domain | WD40_repeat | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 STRAP WDR12 | 5.15e-05 | 272 | 206 | 12 | IPR001680 |
| Domain | WD40_repeat_CS | 8.79e-05 | 164 | 206 | 9 | IPR019775 | |
| Domain | NLE | 1.21e-04 | 2 | 206 | 2 | IPR012972 | |
| Domain | NLE | 1.21e-04 | 2 | 206 | 2 | PF08154 | |
| Domain | TM_rcpt_patched | 1.21e-04 | 2 | 206 | 2 | IPR004766 | |
| Domain | Claudin14 | 1.21e-04 | 2 | 206 | 2 | IPR003556 | |
| Domain | Na_channel_asu | 1.50e-04 | 10 | 206 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.50e-04 | 10 | 206 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.50e-04 | 10 | 206 | 3 | PF06512 | |
| Domain | SPOC_met | 3.61e-04 | 3 | 206 | 2 | IPR010912 | |
| Domain | N2O_reductase_N | 5.46e-04 | 15 | 206 | 3 | IPR011045 | |
| Domain | Desmoglein | 7.16e-04 | 4 | 206 | 2 | IPR009123 | |
| Domain | SSU_processome_Utp12 | 7.16e-04 | 4 | 206 | 2 | IPR007148 | |
| Domain | SPOC | 7.16e-04 | 4 | 206 | 2 | PS50917 | |
| Domain | Utp12 | 7.16e-04 | 4 | 206 | 2 | PF04003 | |
| Domain | - | 1.18e-03 | 5 | 206 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 1.18e-03 | 5 | 206 | 2 | IPR016194 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.26e-05 | 31 | 171 | 5 | M877 | |
| Pubmed | NES MAP1B SPTAN1 COPB2 PSMC2 BIRC6 WDR43 NUP205 WDR3 URB1 SYNE2 NLE1 KIF5B PLOD1 UTRN CLUH RBM15 UBR4 CHD7 ECPAS IGF2R CEBPZ NAT10 EIF5B WDR12 SPEN SNRNP200 | 7.44e-15 | 653 | 214 | 27 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 ZNF280D TRIO SPTAN1 COPB2 PFKM WDR43 NUP205 WDR3 SLC38A2 URB1 PKM KIF5B MED23 QARS1 CLUH MCOLN2 RBM15 DSG1 UBR4 DNM1L PRC1 ECPAS NAMPT IGF2R STRAP CEBPZ PEBP1 NAT10 CD47 EIF5B SLC7A5 WDR12 SPEN SNRNP200 | 2.83e-12 | 1425 | 214 | 35 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES HK2 MAP1B SPTAN1 COPB2 PSMC2 PFKM BIRC6 NUP205 WDR3 URB1 SGPL1 PKM PKP2 NLE1 KIF5B WDR1 QARS1 PLOD1 UTRN FNDC3B RBM15 HDAC6 DSG1 UBR4 WDR70 CHD7 ARG1 NAMPT CEBPZ NAT10 EIF5B SNRNP200 | 1.55e-11 | 1353 | 214 | 33 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES MAP1B ITPRID2 WDR43 NUP205 WDR3 URB1 SYNE2 ZBTB21 PKM NLE1 KIF5B CPSF2 QARS1 PLOD1 UTRN RBM15 NIBAN1 DSG1 CIT ARG1 IGF2R CEBPZ NAT10 EIF5B MARK2 SPEN SNRNP200 | 4.73e-11 | 1024 | 214 | 28 | 24711643 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SPTAN1 ITPRID2 WDR43 NUP205 WDR3 FZR1 SGPL1 PKM PKP2 NLE1 KIF5B WDR1 QARS1 NOL8 KRT3 RBM15 DSG1 PRC1 CIT ARG1 STRAP CEBPZ NOM1 NAT10 EIF5B SLC7A5 WDR12 MARK2 SPEN SNRNP200 | 2.41e-10 | 1257 | 214 | 30 | 36526897 |
| Pubmed | HK2 MAP1B SPTAN1 COPB2 PSMC2 ITPRID2 PFKM NUP205 WDR3 URB1 SGPL1 SYNE2 UNC93B1 WDR1 QARS1 PLOD1 CIP2A UBR4 BAG5 PON2 ECPAS NBAS NAMPT STRAP CEBPZ NOM1 COMMD2 NAT10 EIF5B SLC7A5 SLC39A14 SNRNP200 | 3.39e-10 | 1440 | 214 | 32 | 30833792 | |
| Pubmed | IFT172 SPTAN1 COPB2 PSMC2 NUP205 WDR3 PKM QARS1 NELFCD CIP2A UBR4 BAG5 DNM1L ECPAS SCYL2 NAMPT STRAP NAT10 EIF5B WDR12 SNRNP200 | 5.63e-10 | 638 | 214 | 21 | 33239621 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES MAP1B TRIO MAP2 SPTAN1 KDM3B ITPRID2 PAK6 SLC38A2 SYNE2 CCDC138 ZBTB21 OSBPL10 PKP2 KIF5B UTRN RBM15 NELFCD CEP162 DNM1L LIMK2 MARK2 PCDH7 PRRC1 | 8.70e-10 | 861 | 214 | 24 | 36931259 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES MAP1B NADK2 COPB2 KDM3B PFKM NUP205 BPNT1 SYNE2 PKM OSBPL10 KIF5B WDR1 QARS1 PLOD1 UTRN CLUH HDAC6 DSG1 UBR4 CP ECPAS ARG1 NAMPT IGF2R PEBP1 EIF5B SLC7A5 HAL SLC39A14 | 1.72e-09 | 1367 | 214 | 30 | 32687490 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | LDHAL6A MAP1B MAP2 SPTAN1 OBSCN PSMC2 NUP205 BPNT1 SGPL1 NAV3 PKM ALDH1A3 DSG1 ARG1 YEATS2 NPHP3 IGF2R PEBP1 HAL | 2.66e-09 | 564 | 214 | 19 | 21565611 |
| Pubmed | KDM3B BIRC6 RYR2 WDR3 SLC38A2 PKM OSBPL10 PKP2 FAM135A NOL8 FAT4 CEP162 DNM1L IGF2R PEBP1 NOM1 SLC7A5 SLC39A14 SPEN PCDH7 SNRNP200 PRRC1 | 3.45e-09 | 777 | 214 | 22 | 35844135 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HK2 MAP1B COPB2 NUP205 UBA7 ZBTB21 PKM KIF5B CPSF2 QARS1 TBL1X HDAC6 NELFCD MTERF1 UBR4 WDR70 CPS1 PRC1 ECPAS SEPSECS EIF5B SPEN SNRNP200 | 4.08e-09 | 857 | 214 | 23 | 25609649 |
| Pubmed | MAP1B SPTAN1 IFIT5 PFKM DCC RYR2 NUP205 NRXN3 DGAT2 SYNE2 ZBTB21 PKM NLE1 KIF5B ABCC2 MCF2L KRT3 NELFCD UBR4 GRIA3 GRIA4 MINDY2 SLC12A4 CEBPZ EIF5B SLC7A5 EIF2AK4 POTEJ POLQ SPEN | 5.84e-09 | 1442 | 214 | 30 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B KDM3B PSMC2 PFKM WDR43 ZBTB21 PKM KIF5B WDR1 UTRN NOL8 DSG1 WDR70 DNM1L SNX29 SCYL2 YEATS2 NAMPT STRAP PEBP1 NAT10 EIF5B SNRNP200 | 2.00e-08 | 934 | 214 | 23 | 33916271 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SPTAN1 COPB2 ITPRID2 WDR43 WDR3 PKM PKP2 KIF5B DMBT1 WDR1 RBM15 DSG1 CPS1 PRC1 ARG1 CEBPZ NOM1 NAT10 EIF5B SLC7A5 HAL MARK2 SNRNP200 | 2.68e-08 | 949 | 214 | 23 | 36574265 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HK2 MAP2 SPTAN1 COPB2 KDM3B PSMC2 PFKM BIRC6 NUP205 PKM TIMELESS KIF5B WDR1 QARS1 PLOD1 CLUH NIBAN1 UBR4 BAG5 DNM1L ARMC9 ECPAS DERA NAMPT STRAP EIF5B WDR12 SNRNP200 PRRC1 | 2.73e-08 | 1455 | 214 | 29 | 22863883 |
| Pubmed | MAP2 SPTAN1 ITPRID2 PFKM WDR3 SLC38A2 URB1 SYNE2 CCDC138 NLE1 PLOD1 FAM135A CLUH NOL8 CIP2A UBR4 BAG5 PON2 SNX29 NBAS IGF2R CEBPZ NAT10 EIF5B SLC7A5 WDR12 MARK2 PCDH7 SNRNP200 | 4.36e-08 | 1487 | 214 | 29 | 33957083 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 4.81e-08 | 7 | 214 | 4 | 25818041 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B COPB2 BIRC6 WDR43 NUP205 WDR3 URB1 NLE1 MED23 QARS1 NOL8 RBM15 PRC1 STRAP CEBPZ NOM1 NAT10 WDR12 MARK2 SNRNP200 | 5.97e-08 | 759 | 214 | 20 | 35915203 |
| Pubmed | MAP1B PSMC2 ITPRID2 KIF5B WDR1 MED23 CIP2A IGF2R STRAP PEBP1 NAT10 | 6.36e-08 | 204 | 214 | 11 | 25659154 | |
| Pubmed | MAP1B COPB2 PSMC2 IFIT5 PKM PKP2 KIF5B QARS1 FAM135A HDAC6 CIP2A DNM1L ECPAS SCYL2 IGF2R EIF5B MARK2 PCDH7 SNRNP200 | 9.81e-08 | 708 | 214 | 19 | 39231216 | |
| Pubmed | NES SPTAN1 COPB2 TIMELESS ALDH1A3 MED23 PLOD1 NIBAN1 NT5E UBR4 DERA SLC7A5 PALS2 | 1.33e-07 | 325 | 214 | 13 | 36168628 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KCNH8 MAP1B TRIO MAP2 INPP4A SPTB OBSCN SRF DNAH14 ABCC8 MCF2L PLOD1 UTRN TBL1X WDR70 HECTD4 PON2 ECPAS SNX29 RANBP17 YEATS2 NADSYN1 NAT10 EIF2AK4 PALS2 CATSPERG FBXO21 PDZD2 | 1.61e-07 | 1489 | 214 | 28 | 28611215 |
| Pubmed | TRIO SPTAN1 COPB2 PSMC2 ITPRID2 BIRC6 ZFYVE9 SYNE2 CCDC138 CPSF2 PLOD1 UTRN RBM15 CEP162 CIP2A BAG5 FBXL14 IGF2R SLC12A4 CEBPZ NAT10 EIF2AK4 PCDH7 | 1.61e-07 | 1049 | 214 | 23 | 27880917 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | KCNH8 SPTB PSMC2 ITPRID2 SERPINA1 NAV3 ABCC2 WDR1 QARS1 GNPTAB CP CIT STRAP PEBP1 NOM1 EIF5B HAL MARK2 PRRC1 | 1.64e-07 | 732 | 214 | 19 | 34732716 |
| Pubmed | PIK3AP1 NES TRIO KDM3B BIRC6 SLC38A2 SGPL1 CPSF2 CLUH CIP2A WDR70 CHD7 YEATS2 NBAS IGF2R STRAP CEBPZ SLC7A5 PRRC1 | 1.67e-07 | 733 | 214 | 19 | 34672954 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | HK2 SPTAN1 COPB2 PFKM PKM KIF5B CPSF2 UBR4 DNM1L PRC1 STRAP NAT10 SNRNP200 | 1.70e-07 | 332 | 214 | 13 | 32786267 |
| Pubmed | NES SPTAN1 ITPRID2 WDR43 NUP205 WDR3 PLD2 WDR1 PLOD1 RBM15 NT5E PRC1 CIT STRAP NAT10 EIF5B POTEJ SNRNP200 | 1.71e-07 | 660 | 214 | 18 | 32780723 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | IFT172 COPB2 PSMC2 PFKM NUP205 SERPINA1 PLD2 WDR1 PLOD1 UTRN CLUH CIP2A UBR4 WDR70 PON2 DNM1L FUOM ECPAS SEPSECS MARK2 FBXO21 SNRNP200 | 1.84e-07 | 974 | 214 | 22 | 28675297 |
| Pubmed | KDM3B WDR43 NUP205 SLC38A2 NRXN3 HPS4 ZBTB21 CPSF2 MED23 CEP162 RHOBTB3 HECTD4 ECPAS ARHGEF10L NAT10 EIF2AK4 | 2.15e-07 | 529 | 214 | 16 | 14621295 | |
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 28518218 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 32845893 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 25155934 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 17928448 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 35328104 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO OBSCN KDM3B SLC35E2B PTCH1 BIRC6 FZR1 URB1 SCN8A NLE1 MCF2L UBR4 FBXL14 WDR70 HECTD4 CIT ARHGEF10L NADSYN1 AATK IGF2R SLC12A4 SLC7A5 SPEN | 3.99e-07 | 1105 | 214 | 23 | 35748872 |
| Pubmed | HK2 TRIO BPIFB1 ITPRID2 SGPL1 WDR1 PLOD1 CLUH RAD51D CIP2A UBR4 BAG5 ECPAS IGF2R STRAP NOM1 NAT10 | 4.80e-07 | 634 | 214 | 17 | 34591612 | |
| Pubmed | HK2 MAP1B PSMC2 NUP205 PKM KIF5B WDR1 NIBAN1 DSG1 ARG1 IGF2R SLC7A5 | 6.17e-07 | 312 | 214 | 12 | 37120454 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MAP1B COPB2 SGPL1 CPSF2 UTRN RBM15 ARRDC5 RHOBTB3 UBR4 NPHP3 SPEN SNRNP200 | 6.38e-07 | 313 | 214 | 12 | 38270169 |
| Pubmed | 6.72e-07 | 206 | 214 | 10 | 22174317 | ||
| Pubmed | HK2 MAP1B TRIO MAP2 SPTAN1 COPB2 PSMC2 BIRC6 RYR2 SCN1A NAV3 PKM KIF5B AMPH DSG1 UBR4 GRIA3 GRIA4 CIT NAMPT PEBP1 COMMD2 SLC7A5 | 6.72e-07 | 1139 | 214 | 23 | 36417873 | |
| Pubmed | SPTAN1 BIRC6 SGPL1 CCDC138 PKP2 QARS1 PLOD1 UTRN RBM15 HDAC6 CEP162 BAG5 ECPAS MARK2 | 8.14e-07 | 446 | 214 | 14 | 24255178 | |
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 17537961 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 35031483 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 29578003 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 21156207 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 12752375 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | COPB2 SRF WDR43 WDR3 NLE1 WDR1 MED23 QARS1 DNM1L CEBPZ NOM1 COMMD2 WDR12 SNRNP200 | 1.00e-06 | 454 | 214 | 14 | 33226137 |
| Pubmed | 1.02e-06 | 54 | 214 | 6 | 35474131 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES MAP1B MAP2 SPTAN1 COPB2 NUP205 PKM CPSF2 MED23 PLOD1 RBM15 HDAC6 ARRDC5 HECTD4 CHD7 SIM1 ARG1 NAT10 EIF5B CATSPERG SPEN SNRNP200 | 1.07e-06 | 1082 | 214 | 22 | 38697112 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | COPB2 PSMC2 PAK6 NUP205 ZBTB21 KIF5B CPSF2 RAD51D DSG1 NELFCD CEP162 UBR4 PON2 ECPAS DERA STRAP PEBP1 NOM1 NAT10 TSPAN7 MARK2 POLQ DEDD SNRNP200 | 1.47e-06 | 1284 | 214 | 24 | 17353931 |
| Pubmed | MAP1B TRIO PSMC2 ZBTB21 NLE1 CLUH NOL8 FLT1 HDAC6 CIP2A UBR4 DNM1L ARG1 STRAP WDR12 PALS2 CATSPERG | 1.50e-06 | 689 | 214 | 17 | 36543142 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SPTAN1 KDM3B ITPRID2 ZBTB21 TIMELESS CPSF2 CLUH RBM15 HDAC6 CHD7 ECPAS YEATS2 EIF5B SLC7A5 MARK2 SPEN PCDH7 SNRNP200 | 1.68e-06 | 774 | 214 | 18 | 15302935 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GDPD1 KMT2E NUP205 WDR3 SGPL1 PKM TIMELESS WDR1 MED23 QARS1 PLOD1 CLUH FNDC3B DSG1 CIP2A IGF2R CEBPZ NOM1 CD47 SLC7A5 SLC39A14 SNRNP200 ACSL5 | 1.69e-06 | 1203 | 214 | 23 | 29180619 |
| Pubmed | BPIFB1 WDR43 WDR3 URB1 NLE1 DMBT1 NOL8 SCYL2 STRAP CEBPZ NAT10 EIF5B WDR12 MARK2 | 2.07e-06 | 483 | 214 | 14 | 36912080 | |
| Pubmed | ZNF280D INPP4A BIRC6 GREB1L ZBTB21 UTRN TBL1X NELFCD CIP2A UBR4 CHD7 ECPAS YEATS2 | 2.24e-06 | 418 | 214 | 13 | 34709266 | |
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 16037066 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HK2 NADK2 SPTAN1 COPB2 PSMC2 PFKM BIRC6 SYNE2 PKM KIF5B QARS1 PLOD1 CLUH HDAC6 DSG1 UBR4 BAG5 CPS1 NAMPT STRAP CEBPZ PEBP1 EIF5B SLC7A5 SNRNP200 | 2.39e-06 | 1415 | 214 | 25 | 28515276 |
| Pubmed | NES TRIO SPTAN1 LMO3 SYNE2 ZBTB21 KIF5B WDR1 CPSF2 TBL1X UBR4 HECTD4 DNM1L GRIA3 GRIA4 CHD7 CIT IGF2R STRAP NAT10 | 2.46e-06 | 963 | 214 | 20 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1B SPTAN1 COPB2 URB1 QARS1 PLOD1 CLUH NOL8 FNDC3B DSG1 PRC1 STRAP CEBPZ NOM1 NAT10 EIF5B SPEN | 2.90e-06 | 724 | 214 | 17 | 36232890 |
| Pubmed | 3.13e-06 | 191 | 214 | 9 | 20195357 | ||
| Pubmed | SPTB PAK6 DCC RYR2 SEMA3A PKP2 CPSF2 NLRP8 ATP8B3 NIBAN1 MTERF1 PRDM5 SNX29 ARHGEF10L CD93 AATK PCDH7 PDZD2 | 3.39e-06 | 814 | 214 | 18 | 23251661 | |
| Pubmed | MAP1B COPB2 PSMC2 BIRC6 QARS1 PLOD1 CIP2A UBR4 PON2 ECPAS NAMPT IGF2R STRAP NOM1 SLC7A5 SNRNP200 | 3.62e-06 | 657 | 214 | 16 | 36180527 | |
| Pubmed | 3.64e-06 | 103 | 214 | 7 | 10574462 | ||
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 3.64e-06 | 103 | 214 | 7 | 22623531 | |
| Pubmed | COPB2 OBSCN PTCH1 SLC38A2 URB1 SGPL1 TIMELESS CPSF2 UTRN FAM135A WDFY1 HDAC6 CEP162 DNM1L CHD7 SEPSECS NPHP3 IGF2R NAT10 EIF2AK4 DEDD | 4.02e-06 | 1084 | 214 | 21 | 11544199 | |
| Pubmed | SPTAN1 WDR43 NUP205 WDR3 PKM PKP2 KIF5B CPSF2 QARS1 PLOD1 RBM15 DSG1 CHD7 NAMPT STRAP CEBPZ NOM1 NAT10 WDR12 EIF2AK4 HAL MARK2 POTEJ FBXO21 | 4.51e-06 | 1371 | 214 | 24 | 36244648 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.53e-06 | 6 | 214 | 3 | 23652591 | |
| Pubmed | Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration. | 4.53e-06 | 6 | 214 | 3 | 17182786 | |
| Pubmed | TRIO IFT172 SPTAN1 SPTB IFIT5 LMO3 WDR3 UBA7 HPS4 NAV3 PKM QARS1 UTRN HDAC6 RHOBTB3 GNPTAB UBR4 HECTD4 CIT SCYL2 TSPAN7 PALS2 SNRNP200 | 5.04e-06 | 1285 | 214 | 23 | 35914814 | |
| Pubmed | 5.19e-06 | 153 | 214 | 8 | 10718198 | ||
| Pubmed | 5.27e-06 | 41 | 214 | 5 | 32723828 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HK2 NADK2 PSMC2 ITPRID2 PFKM BIRC6 WDR43 WDR3 SYNE2 CCDC138 PLOD1 CLUH NELFCD CIP2A UBR4 BAG5 DNM1L SCYL2 NBAS PEBP1 NOM1 NAT10 WDR12 MARK2 SLC39A14 | 6.29e-06 | 1496 | 214 | 25 | 32877691 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1B COPB2 PSMC2 BIRC6 NUP205 PKM NLE1 TIMELESS KIF5B WDR1 UBR4 CPS1 NBAS NAMPT CEBPZ SNRNP200 | 8.60e-06 | 704 | 214 | 16 | 29955894 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TRIO INPP4A IFT172 SPTAN1 SGPL1 SCN8A NAV3 PKM MCF2L DSG1 UBR4 WDR70 EIF5B | 8.90e-06 | 475 | 214 | 13 | 31040226 |
| Pubmed | MAP1B SPTAN1 KDM3B PSMC2 PKM KIF5B MED23 SCYL2 YEATS2 STRAP CEBPZ NAT10 SPEN SNRNP200 | 8.91e-06 | 549 | 214 | 14 | 38280479 | |
| Pubmed | NES MAP1B TRIO MAP2 INPP4A SPTAN1 SPTB COPB2 PFKM SGPL1 SCN2A PKM OSBPL10 KIF5B WDR1 UTRN AMPH MTERF1 DNM1L ATP9A CIT PEBP1 MARK2 SNRNP200 | 9.20e-06 | 1431 | 214 | 24 | 37142655 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MAP1B SPTAN1 BIRC6 PKM KIF5B WDR1 UBR4 CPS1 STRAP EIF5B SNRNP200 | 1.06e-05 | 344 | 214 | 11 | 30333137 |
| Pubmed | 1.10e-05 | 282 | 214 | 10 | 23667531 | ||
| Pubmed | Novel raf kinase protein-protein interactions found by an exhaustive yeast two-hybrid analysis. | 1.13e-05 | 23 | 214 | 4 | 12620389 | |
| Pubmed | HK2 SPTAN1 COPB2 PSMC2 PFKM NUP205 WDR3 PKM WDR1 QARS1 RBM15 DSG1 ARG1 NAT10 SNRNP200 | 1.18e-05 | 641 | 214 | 15 | 36057605 | |
| Pubmed | 1.18e-05 | 225 | 214 | 9 | 12168954 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SPTAN1 COPB2 SCN8A PKM WDR1 QARS1 UTRN UBR4 CP ECPAS NBAS NAMPT STRAP PEBP1 EIF5B PALS2 SNRNP200 | 1.20e-05 | 807 | 214 | 17 | 30575818 |
| Pubmed | The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytes. | 1.26e-05 | 8 | 214 | 3 | 37150320 | |
| Pubmed | 1.32e-05 | 288 | 214 | 10 | 38496616 | ||
| Pubmed | SPTAN1 COPB2 PSMC2 ITPRID2 PFKM PKM KIF5B QARS1 ECPAS STRAP NAT10 EIF5B SNRNP200 | 1.35e-05 | 494 | 214 | 13 | 26831064 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MAP2 OBSCN SERPINA1 QARS1 PLOD1 RBM15 FLT1 PCDHB6 ECPAS PDIK1L WDR12 EIF2AK4 MARK2 | 1.44e-05 | 497 | 214 | 13 | 36774506 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MAP1B TRIO PTCH1 SEMA3A SYNE2 PKM QARS1 HDAC6 CHD7 STRAP NAT10 | 1.53e-05 | 358 | 214 | 11 | 32460013 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MAP1B KDM3B PSMC2 IFIT5 NUP205 WDR3 OSBPL10 KIF5B UTRN RBM15 DSG1 BAG5 WDR70 ARG1 IGF2R EIF2AK4 MARK2 DEDD SNRNP200 | 1.65e-05 | 1005 | 214 | 19 | 19615732 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.69e-05 | 130 | 214 | 7 | 35545047 | |
| Pubmed | COPB2 KDM3B NUP205 WDR3 ZBTB21 WDR1 CPSF2 MED23 RBM15 NELFCD UBR4 WDR70 DNM1L PRC1 ECPAS NAMPT PEBP1 NAT10 EIF5B | 1.87e-05 | 1014 | 214 | 19 | 32416067 | |
| Pubmed | TRIO NADK2 SPTAN1 KDM3B PSMC2 PFKM BIRC6 WDR3 SLC38A2 SYNE2 NLE1 QARS1 PLOD1 CLUH UBR4 PON2 DNM1L DERA IGF2R EIF5B WDR12 SLC39A14 | 1.87e-05 | 1297 | 214 | 22 | 33545068 | |
| Pubmed | 1.87e-05 | 26 | 214 | 4 | 17875933 | ||
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 15746173 | ||
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 16382098 | ||
| Pubmed | ITPRID2 WDR43 GREB1L WDR3 URB1 SGPL1 UNC93B1 CPSF2 MED23 UTRN NOL8 FNDC3B NT5E CHD7 ATP9A CIT CEP164 CEBPZ NOM1 EIF5B SLC7A5 WDR12 MARK2 SPEN | 1.92e-05 | 1497 | 214 | 24 | 31527615 | |
| Pubmed | SPTAN1 COPB2 PSMC2 BPIFB1 NUP205 SYNE2 CCDC138 DMBT1 MED23 PLOD1 RBM15 FAT4 ECPAS SLC12A4 NAT10 SNRNP200 | 1.99e-05 | 754 | 214 | 16 | 35906200 | |
| Pubmed | MAP1B TRIO IFT172 SPTAN1 GREB1L PKM TIMELESS FAT4 MTERF1 MINDY2 STRAP DSG4 SNRNP200 | 2.00e-05 | 513 | 214 | 13 | 25798074 | |
| Pubmed | INPP4A KDM3B PSMC2 RYR2 ZFYVE9 PKP2 QARS1 UTRN NELFCD UBR4 SCYL2 LIMK2 SLC12A4 NOM1 | 2.02e-05 | 591 | 214 | 14 | 15231748 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PIK3AP1 TRIO PSMC2 PFKM NUP205 WDR3 CCDC138 KIF5B PLOD1 CEP162 CIP2A CP ECPAS CEP164 IGF2R PEBP1 COMMD2 | 2.42e-05 | 853 | 214 | 17 | 28718761 |
| Interaction | SIRT7 interactions | NES MAP1B SPTAN1 COPB2 PSMC2 BIRC6 WDR43 NUP205 WDR3 URB1 SYNE2 NLE1 KIF5B PLOD1 UTRN CLUH RBM15 UBR4 CHD7 ECPAS IGF2R CEBPZ NAT10 EIF5B WDR12 SPEN SNRNP200 | 1.75e-08 | 744 | 210 | 27 | int:SIRT7 |
| Interaction | RAB11A interactions | TRIO SPTAN1 PTCH1 BIRC6 NUP205 SLC38A2 ZFYVE9 SYNE2 OSBPL10 PKP2 KIF5B FAM135A WDFY1 NIBAN1 NT5E CIP2A DNM1L ATP9A SCYL2 IGF2R SLC12A4 NAT10 SLC7A5 HAL MARK2 SLC39A14 PCDH7 | 1.62e-07 | 830 | 210 | 27 | int:RAB11A |
| Interaction | EED interactions | HK2 MAP1B TRIO SPTAN1 COPB2 OBSCN PSMC2 BIRC6 WDR43 NUP205 WDR3 BPNT1 URB1 SGPL1 PKM PKP2 KIF5B WDR1 CPSF2 PLOD1 CLUH RBM15 CIP2A UBR4 DNM1L CHD7 CIT IGF2R CEBPZ NOM1 NAT10 EIF5B WDR12 MARK2 SPEN SNRNP200 | 8.79e-07 | 1445 | 210 | 36 | int:EED |
| Interaction | ANPEP interactions | NADK2 DNAH14 SLC38A2 ZFYVE9 SYNE2 NIBAN1 HDAC6 UBR4 NAMPT IGF2R SLC39A14 | 2.21e-06 | 174 | 210 | 11 | int:ANPEP |
| Interaction | PRC1 interactions | NES SPTAN1 SPTB PFKM WDR43 NUP205 WDR3 FZR1 URB1 PKP2 WDR1 QARS1 RBM15 CPS1 PRC1 CIT CEBPZ NAT10 EIF5B WDR12 POTEJ SPEN FBXO21 SLC2A12 SNRNP200 PRRC1 PDZD2 | 3.46e-06 | 973 | 210 | 27 | int:PRC1 |
| Interaction | RAB9A interactions | NUP205 SLC38A2 ZFYVE9 SYNE2 PKP2 FAM135A MCOLN2 NIBAN1 NT5E RHOBTB3 DNM1L ATP9A ECPAS SNX29 SCYL2 NBAS IGF2R SLC7A5 MARK2 SLC39A14 | 4.47e-06 | 595 | 210 | 20 | int:RAB9A |
| Interaction | SOX2 interactions | KCNH8 MAP1B SPTAN1 SPTB PSMC2 ITPRID2 WDR3 FZR1 SERPINA1 NAV3 ABCC2 WDR1 QARS1 TBL1X RBM15 NT5E GNPTAB UBR4 BAG5 DNM1L CP CHD7 CIT SCYL2 SEPSECS STRAP PEBP1 NOM1 NAT10 EIF5B HAL MARK2 SPEN PRRC1 | 4.57e-06 | 1422 | 210 | 34 | int:SOX2 |
| Interaction | BIRC3 interactions | ZNF280D TRIO SPTAN1 COPB2 PFKM WDR43 NUP205 WDR3 SLC38A2 URB1 PKM KIF5B WDR1 QARS1 CLUH MCOLN2 RBM15 DSG1 UBR4 DNM1L PRC1 NAMPT STRAP CEBPZ PEBP1 NAT10 CD47 EIF5B SLC7A5 WDR12 SPEN SNRNP200 | 8.49e-06 | 1334 | 210 | 32 | int:BIRC3 |
| Interaction | CFL1 interactions | HK2 LDHAL6A MAP1B FZR1 PKM WDR1 FNDC3B HDAC6 PRC1 CIT ARHGEF10L LIMK2 PEBP1 SPEN PCDH7 | 1.30e-05 | 384 | 210 | 15 | int:CFL1 |
| Interaction | KCNA3 interactions | MAP1B COPB2 PSMC2 IFIT5 PFKM PKM PKP2 KIF5B QARS1 FAM135A HDAC6 CIP2A DNM1L ECPAS SCYL2 YEATS2 IGF2R EIF5B EIF2AK4 MARK2 POLQ SPEN PCDH7 SNRNP200 | 1.42e-05 | 871 | 210 | 24 | int:KCNA3 |
| Interaction | RPS6KL1 interactions | 1.45e-05 | 51 | 210 | 6 | int:RPS6KL1 | |
| Interaction | STIP1 interactions | IFT172 SPTAN1 COPB2 PSMC2 NUP205 WDR3 FZR1 PKM QARS1 HDAC6 NELFCD CIP2A UBR4 BAG5 DNM1L ECPAS ARHGEF10L SCYL2 NAMPT STRAP PEBP1 NAT10 EIF5B WDR12 PCDH7 SNRNP200 | 1.85e-05 | 1006 | 210 | 26 | int:STIP1 |
| Interaction | DIRAS3 interactions | SPTAN1 SLC38A2 PKP2 FAM135A ECPAS SCYL2 IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 PCDH7 | 2.08e-05 | 262 | 210 | 12 | int:DIRAS3 |
| Interaction | OBSL1 interactions | NES MAP2 WDR43 NUP205 WDR3 URB1 SYNE2 PKM NLE1 CPSF2 PLOD1 UTRN RBM15 CIT SNX29 SCYL2 CEBPZ PDIK1L NAT10 EIF5B WDR12 POLQ SPEN SNRNP200 | 2.50e-05 | 902 | 210 | 24 | int:OBSL1 |
| Interaction | EBF2 interactions | 3.39e-05 | 59 | 210 | 6 | int:EBF2 | |
| Interaction | GJA1 interactions | MAP1B TRIO SPTAN1 SLC38A2 ZFYVE9 SYNE2 PKP2 UTRN FAM135A NT5E SCYL2 NBAS IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 PCDH7 | 4.20e-05 | 583 | 210 | 18 | int:GJA1 |
| Interaction | CIT interactions | NES SPTAN1 SPTB COPB2 EMILIN2 PFKM BIRC6 WDR43 NUP205 WDR3 URB1 SYNE2 PKP2 WDR1 CPSF2 QARS1 PLOD1 RBM15 UBR4 CPS1 PRC1 ECPAS CIT NBAS CEBPZ NAT10 EIF5B SLC7A5 WDR12 POTEJ FBXO21 SNRNP200 | 4.41e-05 | 1450 | 210 | 32 | int:CIT |
| Interaction | DNAJB6 interactions | MAP1B KDM3B WDR3 URB1 PKM NLE1 UNC93B1 NOL8 HDAC6 BAG5 CEP164 KBTBD4 WDR12 PRRC1 | 4.66e-05 | 379 | 210 | 14 | int:DNAJB6 |
| Interaction | FLNA interactions | MAP1B TRIO SPTAN1 ITPRID2 FZR1 NLE1 KIF5B WDR1 QARS1 CLUH HDAC6 CEP162 PRC1 CIT KBTBD4 STRAP SLC7A5 WDR12 PCDH7 | 5.13e-05 | 648 | 210 | 19 | int:FLNA |
| Interaction | RAB5A interactions | SPTAN1 NUP205 SLC38A2 FZR1 ZFYVE9 SYNE2 OSBPL10 ALDH1A3 QARS1 FAM135A UBR4 DNM1L CIT SNX29 SCYL2 IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 | 5.22e-05 | 706 | 210 | 20 | int:RAB5A |
| Interaction | SCN4B interactions | 6.01e-05 | 8 | 210 | 3 | int:SCN4B | |
| Interaction | RCOR1 interactions | SPTAN1 OIP5 BIRC6 ZBTB21 MED23 UTRN TBL1X NELFCD CIP2A UBR4 CHD7 ECPAS YEATS2 SEPSECS KBTBD4 SPEN | 6.48e-05 | 494 | 210 | 16 | int:RCOR1 |
| Interaction | NXF1 interactions | NES MAP1B OBSCN PSMC2 PFKM WDR43 NUP205 GREB1L FZR1 URB1 ASB8 UNC93B1 WDR1 QARS1 NOL8 RAD51D RBM15 FAT4 HDAC6 CIP2A UBR4 PRC1 RANBP17 YEATS2 NAMPT STRAP CEBPZ PEBP1 FBXO21 DEDD | 6.49e-05 | 1345 | 210 | 30 | int:NXF1 |
| Interaction | ABCF2 interactions | MAP1B WDR43 FZR1 ZFYVE9 CLUH FLT1 KBTBD4 NAT10 EIF5B SLC2A12 | 7.10e-05 | 209 | 210 | 10 | int:ABCF2 |
| Interaction | LAMTOR1 interactions | PSMC2 PFKM SLC38A2 ZFYVE9 PKP2 FAM135A NIBAN1 HDAC6 NELFCD ATP9A SNX29 SCYL2 NAMPT IGF2R SLC12A4 PEBP1 SLC7A5 MARK2 SLC39A14 PCDH7 | 7.11e-05 | 722 | 210 | 20 | int:LAMTOR1 |
| Interaction | CHMP4B interactions | SPTAN1 SPTB KDM3B ITPRID2 WDR3 SLC38A2 URB1 PKP2 NLE1 WDR1 PLOD1 CPS1 CIT TTC7A IGF2R NAT10 PALS2 SLC2A12 SNRNP200 PDZD2 | 7.81e-05 | 727 | 210 | 20 | int:CHMP4B |
| Interaction | RIT1 interactions | COPB2 SRF PSMC2 BIRC6 WDR43 NUP205 WDR3 NLE1 TIMELESS WDR1 CPSF2 QARS1 NOL8 RAD51D RBM15 NELFCD UBR4 WDR70 PRC1 CIT NAMPT STRAP CEBPZ NAT10 SLC7A5 WDR12 POTEJ SNRNP200 | 8.23e-05 | 1230 | 210 | 28 | int:RIT1 |
| Interaction | DPP4 interactions | SPTAN1 NUP205 ZFYVE9 WDR1 QARS1 PLOD1 RBM15 UBR4 ECPAS NAMPT NAT10 SLC7A5 POTEJ SLC39A14 PCDH7 | 8.61e-05 | 453 | 210 | 15 | int:DPP4 |
| Interaction | NAA40 interactions | MAP1B KDM3B PSMC2 PFKM WDR43 ZBTB21 PKM KIF5B WDR1 UTRN NOL8 DSG1 WDR70 DNM1L CIT SNX29 SCYL2 YEATS2 NAMPT STRAP PEBP1 NAT10 EIF5B SNRNP200 | 8.91e-05 | 978 | 210 | 24 | int:NAA40 |
| Interaction | RPL7A interactions | OBSCN FZR1 SYNE2 NLE1 QARS1 CLUH HDAC6 BAG5 HECTD4 CHD7 ATP9A PRC1 PRDM5 CIT SCYL2 KBTBD4 CEBPZ NOM1 EIF5B | 9.50e-05 | 679 | 210 | 19 | int:RPL7A |
| Interaction | NUP43 interactions | ZNF280D ITPRID2 RYR2 WDR43 WDR3 SYNE2 TIMELESS KIF5B RBM15 DSG1 PRC1 CIT CD93 YEATS2 CEBPZ SPEN SNRNP200 PDZD2 | 1.02e-04 | 625 | 210 | 18 | int:NUP43 |
| Interaction | KIF20A interactions | NES NADK2 SPTAN1 SPTB COPB2 ITPRID2 WDR43 NUP205 WDR3 URB1 SYNE2 NAV3 PKM PKP2 WDR1 CPSF2 UTRN HECTD4 CPS1 PRC1 CIT NAT10 POTEJ SLC2A12 SNRNP200 | 1.05e-04 | 1052 | 210 | 25 | int:KIF20A |
| Interaction | C11orf52 interactions | TRIO SPTAN1 SLC38A2 PKP2 UTRN FAM135A SCYL2 SLC7A5 MARK2 SLC39A14 PALS2 PCDH7 | 1.09e-04 | 311 | 210 | 12 | int:C11orf52 |
| Interaction | RAB35 interactions | TRIO SPTAN1 SLC38A2 ZFYVE9 SYNE2 PKP2 UTRN FAM135A HDAC6 SNX29 SCYL2 IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 PCDH7 | 1.12e-04 | 573 | 210 | 17 | int:RAB35 |
| Interaction | GSK3B interactions | MAP1B TRIO COPB2 PSMC2 BPIFB1 NUP205 CCDC138 PKM KIF5B DMBT1 ALDH1A3 QARS1 UTRN HDAC6 CIP2A DNM1L PRC1 SNX29 ARG1 STRAP CEBPZ MARK2 | 1.12e-04 | 868 | 210 | 22 | int:GSK3B |
| Interaction | SQSTM1 interactions | MAP1B TRIO IFT172 PSMC2 PFKM SLC38A2 SERPINA1 CCDC138 KIF5B UTRN WDFY1 NOL8 HDAC6 NELFCD CIP2A BAG5 DNM1L GRIA3 PRC1 CIT CEP164 SCYL2 YEATS2 LIMK2 IGF2R KBTBD4 PEBP1 EIF5B | 1.19e-04 | 1257 | 210 | 28 | int:SQSTM1 |
| Interaction | RHOJ interactions | SPTAN1 PAK6 PFKM NUP205 SLC38A2 ZFYVE9 PKP2 UTRN FAM135A RBM15 SCYL2 IGF2R SLC12A4 EIF5B SLC7A5 MARK2 SLC39A14 PCDH7 | 1.19e-04 | 633 | 210 | 18 | int:RHOJ |
| Interaction | TOP3B interactions | TRIO SPTAN1 SPTB OBSCN KDM3B SLC35E2B PTCH1 BIRC6 FZR1 URB1 SCN8A PKP2 NLE1 WDR1 MCF2L QARS1 RBM15 UBR4 FBXL14 WDR70 HECTD4 CIT ARHGEF10L NAMPT NADSYN1 AATK IGF2R SLC12A4 STRAP SLC7A5 SPEN | 1.35e-04 | 1470 | 210 | 31 | int:TOP3B |
| Interaction | CTSS interactions | 1.43e-04 | 145 | 210 | 8 | int:CTSS | |
| Interaction | RPS24 interactions | SPTAN1 DCC WDR43 NUP205 WDR3 FZR1 URB1 NOL8 HDAC6 PRC1 ECPAS CIT CEBPZ NOM1 NAT10 PCDH7 | 1.43e-04 | 529 | 210 | 16 | int:RPS24 |
| Interaction | FLOT1 interactions | TRIO SPTAN1 SLC38A2 ZFYVE9 PKP2 UTRN FAM135A HDAC6 PRC1 ECPAS CIT ARG1 SLC12A4 SLC7A5 MARK2 | 1.45e-04 | 475 | 210 | 15 | int:FLOT1 |
| Interaction | ECT2 interactions | NES SPTAN1 SPTB WDR43 NAV3 PKM PKP2 WDR1 CPSF2 PLOD1 CPS1 FANCM CIT CEP164 STRAP CEBPZ NAT10 EIF5B POTEJ SLC2A12 SNRNP200 PDZD2 | 1.53e-04 | 887 | 210 | 22 | int:ECT2 |
| Interaction | NSUN2 interactions | MAP1B WDR43 FZR1 FLT1 HDAC6 BAG5 PRC1 CIT CEP164 CEBPZ PALS2 PCDH7 | 1.55e-04 | 323 | 210 | 12 | int:NSUN2 |
| Interaction | DNAJA1 interactions | MAP1B SPTAN1 PSMC2 FZR1 PLD2 QARS1 HDAC6 NELFCD CIP2A BAG5 DNM1L CIT LIMK2 AATK STRAP PCDH7 | 1.56e-04 | 533 | 210 | 16 | int:DNAJA1 |
| Interaction | CDK1 interactions | NES PAK6 PTCH1 KMT2E FZR1 TIMELESS CLUH FLT1 AMPH HDAC6 CIP2A DNM1L PRC1 CIT SCYL2 AATK KBTBD4 | 1.58e-04 | 590 | 210 | 17 | int:CDK1 |
| Interaction | STX4 interactions | SPTAN1 COPB2 ITPRID2 SLC38A2 SGPL1 SYNE2 UTRN FAM135A NBAS IGF2R SLC7A5 MARK2 SLC39A14 PCDH7 | 1.68e-04 | 428 | 210 | 14 | int:STX4 |
| Interaction | MECP2 interactions | NES MAP1B MAP2 SPTAN1 COPB2 NUP205 URB1 PKM NLE1 CPSF2 MED23 PLOD1 TBL1X NOL8 RBM15 HDAC6 ARRDC5 HECTD4 CHD7 SIM1 PRC1 ARG1 CEBPZ NAT10 EIF5B CATSPERG SPEN SNRNP200 | 1.76e-04 | 1287 | 210 | 28 | int:MECP2 |
| Interaction | LAMP3 interactions | SLC38A2 ZFYVE9 SYNE2 PKP2 FAM135A RHOBTB3 SNX29 SCYL2 IGF2R SLC12A4 COMMD2 SLC7A5 MARK2 SLC39A14 PCDH7 | 1.86e-04 | 486 | 210 | 15 | int:LAMP3 |
| Interaction | AFDN interactions | PAK6 SLC38A2 NRXN3 ZBTB21 PKP2 UTRN HDAC6 FUOM KBTBD4 SLC7A5 MARK2 PCDH7 | 2.05e-04 | 333 | 210 | 12 | int:AFDN |
| Interaction | RPL28 interactions | COPB2 PSMC2 DCC FZR1 URB1 NLE1 NOL8 FNDC3B FAT4 HDAC6 DNM1L CIT KBTBD4 CEBPZ WDR12 | 2.22e-04 | 494 | 210 | 15 | int:RPL28 |
| Interaction | ISG15 interactions | SPTAN1 COPB2 IFIT5 NUP205 UBA7 PKM WDR1 ALDH1A3 QARS1 PLOD1 HDAC6 BAG5 PEBP1 NAT10 SNRNP200 | 2.22e-04 | 494 | 210 | 15 | int:ISG15 |
| Interaction | ACE2 interactions | NES HK2 SPTAN1 SPTB COPB2 PSMC2 PFKM NUP205 WDR3 ZFYVE9 PKM WDR1 QARS1 RBM15 DSG1 NT5E UBR4 CIT TAMALIN ARG1 STRAP NAT10 SLC7A5 POTEJ SNRNP200 | 2.27e-04 | 1106 | 210 | 25 | int:ACE2 |
| Interaction | TMPRSS2 interactions | SPTB PTCH1 BIRC6 SYNE2 QARS1 RBM15 UBR4 PON2 ECPAS NAMPT IGF2R SLC7A5 | 2.29e-04 | 337 | 210 | 12 | int:TMPRSS2 |
| Interaction | KRT8 interactions | NES BIRC6 NUP205 FZR1 SERPINA1 CCDC138 CLUH KRT3 HDAC6 CEP162 UBR4 SCYL2 DEDD PCDH7 | 2.29e-04 | 441 | 210 | 14 | int:KRT8 |
| Interaction | SAR1B interactions | RYR2 SLC38A2 SGPL1 PKM WDR1 NT5E PON2 DNM1L FUOM NAMPT PCDH7 PRRC1 | 2.41e-04 | 339 | 210 | 12 | int:SAR1B |
| Interaction | NUP50 interactions | KDM3B WDR43 WDR3 KIF5B NOL8 HDAC6 NELFCD WDR70 CHD7 CIT YEATS2 SPEN | 2.55e-04 | 341 | 210 | 12 | int:NUP50 |
| Interaction | PDS5A interactions | 2.60e-04 | 245 | 210 | 10 | int:PDS5A | |
| Interaction | STX6 interactions | SPTAN1 COPB2 SLC38A2 ZFYVE9 UTRN FAM135A SCYL2 NBAS IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 PCDH7 | 2.69e-04 | 448 | 210 | 14 | int:STX6 |
| Interaction | ZFPL1 interactions | TRIO SPTAN1 COPB2 SLC38A2 PKP2 UTRN FAM135A DNM1L SCYL2 IGF2R SLC7A5 MARK2 SLC39A14 PCDH7 | 2.69e-04 | 448 | 210 | 14 | int:ZFPL1 |
| Interaction | RND1 interactions | SPTAN1 SLC38A2 FAM135A DSG1 IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 PCDH7 | 2.69e-04 | 246 | 210 | 10 | int:RND1 |
| Interaction | CDC42 interactions | TRIO SPTAN1 PAK6 PFKM NUP205 SLC38A2 SYNE2 OSBPL10 PKP2 MCF2L UTRN FAM135A FNDC3B FAT4 HDAC6 DSG1 ECPAS CIT ARG1 IGF2R SLC12A4 CEBPZ PEBP1 EIF5B SLC7A5 MARK2 SLC39A14 PCDH7 | 2.77e-04 | 1323 | 210 | 28 | int:CDC42 |
| Interaction | VIM interactions | NES MAP1B SPTAN1 PTCH1 FZR1 CCDC138 PKP2 KIF5B KRT3 HDAC6 NELFCD UBR4 DNM1L GRIA4 PRC1 CIT SCYL2 NAT10 EIF5B PCDH7 | 2.97e-04 | 804 | 210 | 20 | int:VIM |
| Interaction | NUPR1 interactions | NES SPTAN1 ITPRID2 WDR43 NUP205 WDR3 PLD2 WDR1 PLOD1 RBM15 NT5E PRC1 CIT STRAP NAT10 EIF5B POTEJ SNRNP200 | 3.02e-04 | 683 | 210 | 18 | int:NUPR1 |
| Interaction | SRRM1 interactions | NES FZR1 SYNE2 NLE1 MED23 WDR70 PRC1 CIT ARHGEF10L EIF5B EIF2AK4 SNRNP200 | 3.06e-04 | 348 | 210 | 12 | int:SRRM1 |
| Interaction | RAC1 interactions | TRIO SPTAN1 PSMC2 PAK6 PFKM NUP205 SLC38A2 HPS4 PKM OSBPL10 PKP2 MCF2L UTRN RBM15 HDAC6 PON2 CIT IGF2R SLC12A4 SLC7A5 DSG4 MARK2 SLC39A14 PCDH7 | 3.10e-04 | 1063 | 210 | 24 | int:RAC1 |
| Interaction | GPR182 interactions | FAAH NUP205 URB1 SGPL1 CCDC138 TIMELESS UNC93B1 PLD2 MED23 CIP2A RHOBTB3 ECPAS LIMK2 NOM1 | 3.14e-04 | 455 | 210 | 14 | int:GPR182 |
| Interaction | RHOA interactions | TRIO SPTAN1 NUP205 SLC38A2 ZFYVE9 SGPL1 SYNE2 OSBPL10 PKP2 MCF2L PLOD1 UTRN FAM135A RBM15 FAT4 PON2 TTPAL CIT SCYL2 IGF2R SLC12A4 SLC7A5 MARK2 SLC39A14 PCDH7 PRRC1 | 3.21e-04 | 1199 | 210 | 26 | int:RHOA |
| Interaction | IFITM3 interactions | SPTAN1 ZFYVE9 SGPL1 OSBPL10 WDR1 QARS1 FAM135A NIBAN1 UBR4 BAG5 SNX29 NAMPT IGF2R SLC7A5 PCDH7 | 3.31e-04 | 513 | 210 | 15 | int:IFITM3 |
| Interaction | QPCTL interactions | 3.37e-04 | 89 | 210 | 6 | int:QPCTL | |
| Interaction | KDM1A interactions | ZNF280D INPP4A OIP5 BIRC6 GREB1L ZBTB21 KIF5B CPSF2 MED23 UTRN TBL1X HDAC6 NELFCD CEP162 CIP2A UBR4 CHD7 ECPAS CIT YEATS2 SEPSECS KBTBD4 | 3.48e-04 | 941 | 210 | 22 | int:KDM1A |
| Interaction | ACTC1 interactions | SPTAN1 KDM3B FZR1 SYNE2 WDR1 QARS1 UTRN HDAC6 WDR70 DNM1L PRC1 CIT SCYL2 YEATS2 AATK PEBP1 POTEJ SNRNP200 | 3.66e-04 | 694 | 210 | 18 | int:ACTC1 |
| Interaction | HNRNPA1 interactions | COPB2 NUP205 FZR1 PKM CPSF2 QARS1 PLOD1 RBM15 HDAC6 DSG1 PRC1 ECPAS CIT ARG1 NAMPT STRAP NAT10 HAL MARK2 PCDH7 SNRNP200 PRRC1 | 3.68e-04 | 945 | 210 | 22 | int:HNRNPA1 |
| Interaction | ITLN2 interactions | 3.71e-04 | 59 | 210 | 5 | int:ITLN2 | |
| Interaction | SERPINH1 interactions | MAP1B COPB2 FZR1 FLT1 UBR4 PRC1 CIT ARHGEF10L LIMK2 AATK PEBP1 | 3.84e-04 | 306 | 210 | 11 | int:SERPINH1 |
| Interaction | FSAF1 interactions | 4.02e-04 | 60 | 210 | 5 | int:FSAF1 | |
| Interaction | OTULIN interactions | 4.05e-04 | 169 | 210 | 8 | int:OTULIN | |
| Interaction | RPL4 interactions | GREB1L WDR3 FZR1 URB1 PKM MCF2L NOL8 HDAC6 BAG5 PRC1 PRDM5 CIT KBTBD4 CEBPZ NOM1 NAT10 WDR12 SPEN SNRNP200 | 4.23e-04 | 764 | 210 | 19 | int:RPL4 |
| Interaction | ATG10 interactions | 4.54e-04 | 216 | 210 | 9 | int:ATG10 | |
| Cytoband | 2q24.3 | 5.35e-05 | 16 | 214 | 3 | 2q24.3 | |
| GeneFamily | WD repeat domain containing | IFT172 COPB2 WDR43 WDR3 FZR1 NLE1 WDR1 WDFY1 TBL1X WDR70 STRAP WDR12 | 1.70e-06 | 262 | 148 | 12 | 362 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.35e-05 | 9 | 148 | 3 | 1203 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 3.95e-04 | 4 | 148 | 2 | 1200 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.36e-03 | 7 | 148 | 2 | 1113 | |
| GeneFamily | Desmosomal cadherins | 1.36e-03 | 7 | 148 | 2 | 1188 | |
| GeneFamily | Solute carriers | SLC35E2B SLC38A2 SLC25A53 SLC38A11 SLC9A6 SLC17A5 SLC12A4 SLC7A5 SLC39A14 SLC2A12 | 1.56e-03 | 395 | 148 | 10 | 752 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.10e-03 | 66 | 148 | 4 | 722 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.49e-03 | 11 | 148 | 2 | 1168 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.78e-03 | 181 | 148 | 6 | 694 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | HK2 TRIO ITPRID2 SEMA3A SLC38A2 OSBPL10 KIF5B CPSF2 NOL8 CIP2A RHOBTB3 DNM1L TTPAL SCYL2 NAMPT CEBPZ COMMD2 ST6GALNAC5 EIF5B SLC7A5 | 2.00e-06 | 721 | 213 | 20 | M10237 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MAP1B MAP2 PTCH1 ABCC8 HPS4 SYNE2 PKP2 KIF5B SETD3 UTRN NANOS1 FAM135A HECTD4 GRIA4 CHD7 ECPAS SNX29 PEBP1 TSPAN7 SLC39A14 PALS2 PCDH7 PDZD2 | 3.07e-06 | 946 | 213 | 23 | M39169 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GDPD1 KCNH8 MAP1B MAP2 INPP4A DCC KMT2E RYR2 SEMA3A NRXN3 SCN1A SCN2A SCN8A NAV3 MCF2L SLC9A6 PDZRN4 GNPTAB GRIA4 ATP9A AATK PDIK1L TSPAN7 CATSPERG PCDH7 | 4.03e-06 | 1106 | 213 | 25 | M39071 |
| Coexpression | TRAVAGLINI_LUNG_NEUTROPHIL_CELL | CATIP SPTAN1 SLC35E2B DGAT2 PKM TBL1X NIBAN1 ARG1 LIMK2 NAMPT IGF2R CEBPZ HAL | 1.04e-05 | 366 | 213 | 13 | M41688 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 1.77e-05 | 40 | 213 | 5 | MM17488 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GDPD1 MAP1B MAP2 RYR2 URB1 NRXN3 SCN1A SCN2A SCN8A MCF2L SLC9A6 AMPH GNPTAB GRIA4 ATP9A AATK TSPAN7 PCDH7 | 1.94e-05 | 703 | 213 | 18 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | KCNH8 MAP1B MAP2 DCC RYR2 NRXN3 SCN2A SCN8A SLC9A6 AMPH GNPTAB GRIA4 AATK PCDH7 | 2.99e-05 | 465 | 213 | 14 | M39066 |
| Coexpression | MCCLUNG_COCAINE_REWARD_5D | 3.39e-05 | 75 | 213 | 6 | M1539 | |
| Coexpression | MCCLUNG_COCAINE_REWARD_5D | 3.39e-05 | 75 | 213 | 6 | MM658 | |
| Coexpression | GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN | 3.72e-05 | 198 | 213 | 9 | M7707 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN | 3.87e-05 | 199 | 213 | 9 | M8960 | |
| Coexpression | GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN | 4.02e-05 | 200 | 213 | 9 | M7334 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 4.02e-05 | 200 | 213 | 9 | M8972 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | MAP1B MAP2 SEMA3A SGPL1 ABCC8 SLC38A11 MCF2L TBL1X AMPH ARHGEF10L ST6GALNAC5 TSPAN7 SLC7A5 | 5.40e-05 | 429 | 213 | 13 | M45694 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NES INPP4A NADK2 ITPRID2 KITLG KIF5B MED23 FAM135A WDFY1 FNDC3B FLT1 NT5E PON2 ECPAS MINDY2 SLC17A5 CD47 SLC2A12 PLCE1 | 7.60e-05 | 854 | 213 | 19 | M1533 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | MAP1B MAP2 LMO3 DCC NRXN3 ABCC8 SCN2A SCN8A PDZRN4 GNPTAB GRIA3 ATP9A AATK TSPAN7 | 8.56e-05 | 513 | 213 | 14 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | KCNH8 MAP1B MAP2 PFKM SEMA3A ABCC8 SCN8A MCF2L GRIA4 AATK TSPAN7 PCDH7 | 8.84e-05 | 389 | 213 | 12 | M39073 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | WDR43 SLC38A2 FZR1 URB1 UTRN WDFY1 TBL1X RAD51D NIBAN1 RHOBTB3 C1orf74 MINDY2 SCYL2 LIMK2 SEPSECS NPHP3 NAMPT IGF2R SLC39A14 PALS2 | 9.26e-05 | 942 | 213 | 20 | M8144 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | MAP2 SPTAN1 ZFYVE9 KIF5B PON2 TTC7A RANBP17 ST6GALNAC5 TSPAN7 CD47 PLCE1 PDZD2 | 9.28e-05 | 391 | 213 | 12 | M41659 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NES INPP4A NADK2 ITPRID2 KITLG KIF5B MED23 FAM135A WDFY1 FNDC3B FLT1 NT5E PON2 ECPAS MINDY2 SLC17A5 CD47 SLC2A12 PLCE1 | 1.26e-04 | 888 | 213 | 19 | MM1018 |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | 1.32e-04 | 183 | 213 | 8 | M8178 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | EMILIN2 KDM3B SERPINA1 UBA7 KIF5B WDR1 FNDC3B NIBAN1 SLC7A5 SPEN | 1.57e-04 | 294 | 213 | 10 | M40873 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | OIP5 NUP205 WDR3 NLE1 TIMELESS QARS1 ARMC9 CHD7 PRC1 ECPAS YEATS2 NAT10 EIF5B WDR12 SNRNP200 | 1.57e-04 | 612 | 213 | 15 | M4772 |
| Coexpression | IL2_UP.V1_UP | 1.71e-04 | 190 | 213 | 8 | M2822 | |
| Coexpression | INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP | 1.80e-04 | 14 | 213 | 3 | M1256 | |
| Coexpression | SEMENZA_HIF1_TARGETS | 2.04e-04 | 36 | 213 | 4 | M12299 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN | 2.04e-04 | 195 | 213 | 8 | M9508 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP | 2.11e-04 | 196 | 213 | 8 | M5313 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 2.22e-04 | 307 | 213 | 10 | M39058 | |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_UP | 2.33e-04 | 68 | 213 | 5 | M1549 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN | 2.34e-04 | 199 | 213 | 8 | M6048 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_DN | 2.34e-04 | 199 | 213 | 8 | M8777 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.34e-04 | 199 | 213 | 8 | M5357 | |
| Coexpression | GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN | 2.42e-04 | 200 | 213 | 8 | M8096 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.42e-04 | 200 | 213 | 8 | M304 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP | 2.42e-04 | 200 | 213 | 8 | M7077 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN | 2.42e-04 | 200 | 213 | 8 | M9632 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP | 2.42e-04 | 200 | 213 | 8 | M9836 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 2.42e-04 | 200 | 213 | 8 | M6095 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_DN | 2.42e-04 | 200 | 213 | 8 | M6431 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | 2.42e-04 | 200 | 213 | 8 | M6544 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL | 2.66e-04 | 70 | 213 | 5 | M45690 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | NADK2 WDR3 KIF5B CPSF2 CIP2A RHOBTB3 DNM1L ARMC9 PRC1 CIT NAMPT CEBPZ EIF5B WDR12 SLC39A14 | 2.71e-04 | 644 | 213 | 15 | M10501 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | GDPD1 NES ZNF280D MAP1B MAP2 SPTAN1 PTCH1 SYNE2 CCDC138 SCN8A SLC25A53 RAD51D AMPH HDAC6 CEP162 CIP2A RHOBTB3 CHD7 SIM1 PRC1 FANCM TAMALIN TTC7A RANBP17 NPHP3 KBTBD4 PDIK1L PTCH2 SLC2A12 PLCE1 | 2.42e-05 | 1370 | 206 | 30 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.57e-05 | 89 | 206 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | ZNF280D SYNE2 MED23 UTRN CHD7 SIM1 ECPAS FANCM ST6GALNAC5 EIF2AK4 | 3.06e-05 | 203 | 206 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 |
| CoexpressionAtlas | e10.5_Emin_MedialNasal_top-relative-expression-ranked_500_2 | 4.52e-05 | 21 | 206 | 4 | Facebase_ST1_e10.5_Emin_MedialNasal_500_2 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | HK2 SYNE2 INTS6L CIP2A RHOBTB3 GRIA3 PRC1 PRDM5 RANBP17 CD93 TSPAN7 WDR12 POLQ PCDH7 | 5.06e-05 | 410 | 206 | 14 | GSM791122_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | MAP1B ASPN NADK2 PTCH1 RYR2 SEMA3A GRHL1 NRXN3 ZBTB21 CPSF2 FAM135A WDFY1 FAT4 NIBAN1 CIP2A PON2 TTPAL SCYL2 CD47 PCDH7 PRRC1 | 5.71e-05 | 826 | 206 | 21 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | GDPD1 NES ZNF280D MAP1B MAP2 PAK6 SLC35E2B PTCH1 URB1 NRXN3 SYNE2 CCDC138 SCN8A NOL8 CEP162 CIP2A RHOBTB3 CP CHD7 SIM1 PRC1 FANCM CIT RANBP17 PRELID3A PDIK1L NAT10 PTCH2 CATSPERG | 1.07e-04 | 1414 | 206 | 29 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TRIO SPTAN1 ITPRID2 BIRC6 SYNE2 MCF2L UTRN FAM135A FAT4 FLT1 CHD7 CD93 | 2.75e-10 | 200 | 214 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MAP1B MAP2 RYR2 NRXN3 SCN1A SCN2A SCN8A AMPH GRIA3 TSPAN7 PALS2 | 3.47e-09 | 198 | 214 | 11 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B ASPN DCC RYR2 SEMA3A ABCC8 NAV3 PDZRN4 ST6GALNAC5 PCDH7 | 3.03e-08 | 190 | 214 | 10 | 562ee3b025c29edf07b8b344323edb49d82f1c7e |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B ASPN DCC RYR2 SEMA3A ABCC8 NAV3 PDZRN4 ST6GALNAC5 PCDH7 | 3.03e-08 | 190 | 214 | 10 | f5fb989afabb49d64d91324570cd8c80a4b9e67d |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.47e-08 | 198 | 214 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.47e-08 | 198 | 214 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 4.91e-08 | 200 | 214 | 10 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-07 | 180 | 214 | 9 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-07 | 181 | 214 | 9 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-07 | 182 | 214 | 9 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.93e-07 | 185 | 214 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.07e-07 | 186 | 214 | 9 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.84e-07 | 191 | 214 | 9 | b9b091d6b352d5128bb864ff52d2e5fb3387b766 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-07 | 144 | 214 | 8 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-07 | 198 | 214 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.65e-07 | 200 | 214 | 9 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 173 | 214 | 8 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 173 | 214 | 8 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 177 | 214 | 8 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 177 | 214 | 8 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 177 | 214 | 8 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 177 | 214 | 8 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 182 | 214 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 186 | 214 | 8 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 186 | 214 | 8 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 3.40e-06 | 186 | 214 | 8 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 187 | 214 | 8 | f491ec986dd44e2dabdf4a75c3101e3b6c921872 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | PIK3AP1 SERPINA1 OSBPL10 SLC38A11 MCF2L SIM1 ARHGEF10L PALS2 | 3.53e-06 | 187 | 214 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 187 | 214 | 8 | 96dc5dc4dbc1b33c2e66666e9027cfbf7972090b | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 187 | 214 | 8 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-06 | 188 | 214 | 8 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-06 | 188 | 214 | 8 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-06 | 188 | 214 | 8 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-06 | 188 | 214 | 8 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-06 | 188 | 214 | 8 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-06 | 189 | 214 | 8 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-06 | 189 | 214 | 8 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-06 | 189 | 214 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-06 | 189 | 214 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-06 | 189 | 214 | 8 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 190 | 214 | 8 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 190 | 214 | 8 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-06 | 190 | 214 | 8 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.97e-06 | 190 | 214 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-06 | 190 | 214 | 8 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-06 | 190 | 214 | 8 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 190 | 214 | 8 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.97e-06 | 190 | 214 | 8 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-06 | 191 | 214 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-06 | 191 | 214 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.13e-06 | 191 | 214 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-06 | 192 | 214 | 8 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 193 | 214 | 8 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 194 | 214 | 8 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 194 | 214 | 8 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 4.63e-06 | 194 | 214 | 8 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.63e-06 | 194 | 214 | 8 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 4.63e-06 | 194 | 214 | 8 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.81e-06 | 195 | 214 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-06 | 196 | 214 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 5.19e-06 | 197 | 214 | 8 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.19e-06 | 197 | 214 | 8 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-06 | 198 | 214 | 8 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-06 | 198 | 214 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.59e-06 | 199 | 214 | 8 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 199 | 214 | 8 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.59e-06 | 199 | 214 | 8 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.59e-06 | 199 | 214 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 5.59e-06 | 199 | 214 | 8 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.59e-06 | 199 | 214 | 8 | 7271dbeca9aa838b88ad44d00059263a29c0316b | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-06 | 199 | 214 | 8 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.59e-06 | 199 | 214 | 8 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.80e-06 | 200 | 214 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.80e-06 | 200 | 214 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 5.80e-06 | 200 | 214 | 8 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.80e-06 | 200 | 214 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.80e-06 | 200 | 214 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-06 | 200 | 214 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.80e-06 | 200 | 214 | 8 | ec9a18576a3d08ddfceb70d114c4ab861fbb0d08 | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.80e-06 | 200 | 214 | 8 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.80e-06 | 200 | 214 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 746e8f61411f8e68b988152ab36561991f716a0a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-06 | 200 | 214 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.24e-06 | 147 | 214 | 7 | 50a855aa7f214c3be8ac46a22adf9bc9dd0285db | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 159 | 214 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 160 | 214 | 7 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 160 | 214 | 7 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 160 | 214 | 7 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.15e-07 | 145 | 204 | 9 | DOID:1289 (implicated_via_orthology) | |
| Disease | X-21467 measurement | 2.65e-05 | 9 | 204 | 3 | EFO_0020007 | |
| Disease | L-arginine measurement | 3.44e-05 | 27 | 204 | 4 | EFO_0006524 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.77e-05 | 10 | 204 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.77e-05 | 10 | 204 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | stimulant use measurement | 3.99e-05 | 28 | 204 | 4 | EFO_0600076 | |
| Disease | melanoma | 6.16e-05 | 248 | 204 | 9 | C0025202 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 6.84e-05 | 12 | 204 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | age at first sexual intercourse measurement | KCNH8 DCC NUP205 SERPINA1 SCN2A UTRN PDZRN4 GRIA4 SNX29 RANBP17 AATK | 7.95e-05 | 383 | 204 | 11 | EFO_0009749 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.45e-05 | 152 | 204 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | histidine measurement | 9.54e-05 | 66 | 204 | 5 | EFO_0009769 | |
| Disease | Colorectal Carcinoma | MAP1B MAP2 OBSCN PAK6 DCC ABCC8 ABCC2 NLRP8 PDZRN4 ARHGEF10L CD93 NAMPT STRAP SNRNP200 ACSL5 | 1.21e-04 | 702 | 204 | 15 | C0009402 |
| Disease | Benign familial infantile epilepsy | 1.42e-04 | 3 | 204 | 2 | cv:C5575231 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.42e-04 | 3 | 204 | 2 | C0349788 | |
| Disease | Hair Diseases | 1.42e-04 | 3 | 204 | 2 | C0018500 | |
| Disease | neuroticism measurement, cognitive function measurement | LMO3 DCC PTCH1 BIRC6 SCN2A OSBPL10 SETD3 NANOS1 SIM1 SNX29 DERA AATK RAB40C | 1.71e-04 | 566 | 204 | 13 | EFO_0007660, EFO_0008354 |
| Disease | smoking status measurement | LMO3 PFKM DCC BIRC6 RYR2 FZR1 NRXN3 CLDN17 SCN2A WDR1 SETD3 UTRN MTERF1 HECTD4 CHD7 PRDM5 SNX29 RANBP17 CD47 PALS2 | 1.71e-04 | 1160 | 204 | 20 | EFO_0006527 |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 2.83e-04 | 4 | 204 | 2 | 605462 | |
| Disease | asporin measurement | 2.83e-04 | 4 | 204 | 2 | EFO_0801397 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 2.83e-04 | 4 | 204 | 2 | cv:C2751544 | |
| Disease | Oculo-dento-digital syndrome | 2.83e-04 | 4 | 204 | 2 | C0812437 | |
| Disease | Parkinson Disease | 3.15e-04 | 85 | 204 | 5 | C0030567 | |
| Disease | disease of metabolism (implicated_via_orthology) | 3.95e-04 | 21 | 204 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | CLDN14 DNAH14 DMBT1 CPSF2 UTRN FAM135A SIM1 SNX29 SCYL2 RANBP17 EIF2AK4 SLC2A12 PDZD2 | 4.03e-04 | 619 | 204 | 13 | EFO_0003923, EFO_0004531 |
| Disease | anxiety disorder (implicated_via_orthology) | 4.55e-04 | 22 | 204 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | generalised epilepsy | 4.63e-04 | 52 | 204 | 4 | EFO_0005917 | |
| Disease | N-acetylglucosaminylasparagine measurement | 4.69e-04 | 5 | 204 | 2 | EFO_0800151 | |
| Disease | cholestasis (is_marker_for) | 4.69e-04 | 5 | 204 | 2 | DOID:13580 (is_marker_for) | |
| Disease | Basal Cell Nevus Syndrome | 4.69e-04 | 5 | 204 | 2 | C0004779 | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 4.77e-04 | 93 | 204 | 5 | C1535926 | |
| Disease | body weight | PAK6 DCC PTCH1 DNAH14 SLC38A2 NRXN3 ABCC8 CPSF2 PDZRN4 NELFCD WDR70 HECTD4 CHD7 SIM1 CPS1 PRDM5 NBAS AATK PCDH7 PDZD2 | 5.01e-04 | 1261 | 204 | 20 | EFO_0004338 |
| Disease | Disorder of the urea cycle metabolism | 7.01e-04 | 6 | 204 | 2 | cv:C0154246 | |
| Disease | X-21471 measurement | 7.01e-04 | 6 | 204 | 2 | EFO_0800818 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 7.01e-04 | 6 | 204 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | brain edema (implicated_via_orthology) | 7.01e-04 | 6 | 204 | 2 | DOID:4724 (implicated_via_orthology) | |
| Disease | Familial benign neonatal epilepsy | 7.01e-04 | 6 | 204 | 2 | C0220669 | |
| Disease | X-16570 measurement | 7.01e-04 | 6 | 204 | 2 | EFO_0800759 | |
| Disease | fibrinogen measurement, coronary artery disease | 7.30e-04 | 154 | 204 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | Kallmann Syndrome | 7.53e-04 | 26 | 204 | 3 | C0162809 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 8.07e-04 | 157 | 204 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 9.76e-04 | 7 | 204 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 9.76e-04 | 7 | 204 | 2 | C0751057 | |
| Disease | Immune System Diseases | 9.76e-04 | 7 | 204 | 2 | C0021053 | |
| Disease | N-palmitoylglycine measurement | 9.76e-04 | 7 | 204 | 2 | EFO_0800342 | |
| Disease | epilepsy (implicated_via_orthology) | 9.80e-04 | 163 | 204 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | vital capacity | MAP2 DCC PTCH1 KMT2E RYR2 SEMA3A SERPINA1 COL21A1 UTRN FLT1 CEP162 WDR70 CHD7 ATP9A PRDM5 PDIK1L SLC2A12 PLCE1 PDZD2 | 1.00e-03 | 1236 | 204 | 19 | EFO_0004312 |
| Disease | Intellectual Disability | 1.17e-03 | 447 | 204 | 10 | C3714756 | |
| Disease | risky sexual behaviour measurement | 1.18e-03 | 169 | 204 | 6 | EFO_0007877 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.28e-03 | 68 | 204 | 4 | EFO_0007826, EFO_0007860 | |
| Disease | argininate measurement | 1.30e-03 | 8 | 204 | 2 | EFO_0800055 | |
| Disease | Myocardial Ischemia | 1.45e-03 | 176 | 204 | 6 | C0151744 | |
| Disease | Nephronophthisis | 1.66e-03 | 9 | 204 | 2 | cv:C0687120 | |
| Disease | Silicosis | 1.66e-03 | 9 | 204 | 2 | C0037116 | |
| Disease | Febrile Convulsions | 1.66e-03 | 9 | 204 | 2 | C0009952 | |
| Disease | underweight body mass index status | 1.66e-03 | 9 | 204 | 2 | EFO_0005936 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.66e-03 | 9 | 204 | 2 | C3502809 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.66e-03 | 34 | 204 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | JT interval | 1.76e-03 | 248 | 204 | 7 | EFO_0007885 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.00e-03 | 128 | 204 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.00e-03 | 128 | 204 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.00e-03 | 128 | 204 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.00e-03 | 128 | 204 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.00e-03 | 128 | 204 | 5 | C0007134 | |
| Disease | N6-acetyllysine measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0800036 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 2.06e-03 | 10 | 204 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | leptin measurement | 2.44e-03 | 81 | 204 | 4 | EFO_0005000 | |
| Disease | serum metabolite measurement | TRIO FAAH SLC38A2 SYNE2 ABCC2 WDR1 PDZRN4 NELFCD NT5E CPS1 CIT ARG1 IGF2R SLC7A5 HAL | 2.51e-03 | 945 | 204 | 15 | EFO_0005653 |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.51e-03 | 11 | 204 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | diastolic blood pressure, systolic blood pressure | MAP1B KMT2E RYR2 WDR43 COL21A1 FNDC3B FLT1 MTERF1 PON2 ARMC9 CEP164 EPHX3 | 2.56e-03 | 670 | 204 | 12 | EFO_0006335, EFO_0006336 |
| Disease | cortical surface area measurement | MAP2 PTCH1 SLC38A2 SERPINA1 NAV3 WDR1 MED23 SETD3 QARS1 PDZRN4 CEP162 CHD7 CPS1 PRDM5 ARG1 SEPSECS PCDH7 PLCE1 PDZD2 | 2.61e-03 | 1345 | 204 | 19 | EFO_0010736 |
| Disease | Drug toxicity | 2.78e-03 | 84 | 204 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 2.78e-03 | 84 | 204 | 4 | C0041755 | |
| Disease | Autism Spectrum Disorders | 2.90e-03 | 85 | 204 | 4 | C1510586 | |
| Disease | ascending aortic diameter | 2.95e-03 | 140 | 204 | 5 | EFO_0021787 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 3.00e-03 | 12 | 204 | 2 | C0403553 | |
| Disease | basal cell carcinoma (is_implicated_in) | 3.00e-03 | 12 | 204 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | thyroid gland carcinoma (is_marker_for) | 3.00e-03 | 12 | 204 | 2 | DOID:3963 (is_marker_for) | |
| Disease | neuroimaging measurement | MAP1B MAP2 LMO3 PAK6 DCC PTCH1 SEMA3A SERPINA1 NAV3 WDR1 SETD3 ARMC9 CHD7 SLC39A14 PCDH7 PLCE1 | 3.24e-03 | 1069 | 204 | 16 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | SPTAN1 OBSCN FAAH SEMA3A SYNE2 NLE1 TIMELESS PLD2 PLOD1 NLRP8 FNDC3B FLT1 UBR4 SIM1 PRC1 SPEN | 3.39e-03 | 1074 | 204 | 16 | C0006142 |
| Disease | hemoglobin A1 measurement | SPTB PFKM FZR1 SERPINA1 ABCC8 SYNE2 TBL1X FNDC3B PRC1 SNRNP200 | 3.50e-03 | 520 | 204 | 10 | EFO_0007629 |
| Disease | Amino Acid Metabolism, Inherited Disorders | 3.53e-03 | 13 | 204 | 2 | C0750905 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.53e-03 | 13 | 204 | 2 | C0751122 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 3.53e-03 | 13 | 204 | 2 | C0002514 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.57e-03 | 90 | 204 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | interleukin 17 measurement | 3.73e-03 | 45 | 204 | 3 | EFO_0008174 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.74e-03 | 148 | 204 | 5 | C0279702 | |
| Disease | phosphatidylcholine measurement | 3.75e-03 | 284 | 204 | 7 | EFO_0010226 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | DCC BIRC6 RYR2 UBA7 NRXN3 CLDN17 SCN2A UTRN GRIA4 CHD7 RANBP17 AATK PCDH7 | 3.98e-03 | 801 | 204 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | respiratory quotient | 4.10e-03 | 14 | 204 | 2 | EFO_0005189 | |
| Disease | response to selective serotonin reuptake inhibitor, openness measurement | 4.10e-03 | 14 | 204 | 2 | EFO_0005658, EFO_0007914 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 4.10e-03 | 14 | 204 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | Asbestosis | 4.10e-03 | 14 | 204 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 4.10e-03 | 14 | 204 | 2 | C2930617 | |
| Disease | Gastrointestinal Stromal Sarcoma | 4.22e-03 | 47 | 204 | 3 | C3179349 | |
| Disease | multisite chronic pain | 4.33e-03 | 95 | 204 | 4 | EFO_0010100 | |
| Disease | Hereditary Diffuse Gastric Cancer | 4.44e-03 | 293 | 204 | 7 | C1708349 | |
| Disease | small vessel stroke | 4.49e-03 | 96 | 204 | 4 | EFO_1001504 | |
| Disease | glutamine measurement | 4.66e-03 | 97 | 204 | 4 | EFO_0009768 | |
| Disease | unipolar depression, bipolar disorder | 4.68e-03 | 156 | 204 | 5 | EFO_0003761, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLEYEATEILQKGSG | 926 | Q6N043 | |
| LLLLVESGYGNASKR | 416 | Q6ZRH7 | |
| LGLQDGSILLYSSVD | 896 | Q9HCE6 | |
| TEGYDLFITQLKDGL | 186 | Q9NR09 | |
| ELYLSSKTELQGLIG | 301 | Q9UL15 | |
| GDTIQLYLGAKLLDS | 241 | Q8TDL5 | |
| LYLGAKLLDSQGKVT | 246 | Q8TDL5 | |
| TKDAGLGVYSLALLN | 256 | Q9P2I0 | |
| TLQSELVGQLYKSSL | 681 | O00429 | |
| QLGKLVYNALETATG | 291 | Q9P2K8 | |
| GDKELNIISYSLLVS | 576 | P35606 | |
| SITGTYDLKSVLGQL | 316 | P01009 | |
| DSTSGQVTLIGKLDY | 1261 | Q6V0I7 | |
| LTALYLGSLIKEAGF | 211 | P47895 | |
| TDGQKLLLFYILGTV | 576 | Q9NPY3 | |
| LQSYLEELKGLGFLT | 66 | Q96LT6 | |
| LGQVEYIFSDKTGTL | 486 | O60423 | |
| RDYINGSLLEALKGV | 261 | O75618 | |
| SGNVSLKIYSGDLVV | 241 | Q6ZUJ8 | |
| GTKEYTEGLLDNVTV | 121 | O95861 | |
| LGAGKTTLLNYILTE | 51 | Q5RIA9 | |
| GLGKTIQSITFLYEI | 996 | Q9P2D1 | |
| LVGTEEGLYALNVLK | 1606 | O14578 | |
| DFKGLTSLYGLILNN | 121 | Q9BXN1 | |
| TEEIYKTGLLSGLDI | 261 | P05089 | |
| QKLVDGSLLTLDTYL | 111 | P49418 | |
| NERAKAYLLGTSGVL | 111 | P56750 | |
| KLLDAGLYTGEVTEI | 91 | O75771 | |
| TYGNQILSLGSLSKD | 806 | Q9H2T7 | |
| GAEYKTLKISELGSQ | 166 | Q96T37 | |
| SNGIDYKTTTILLDG | 46 | Q96S21 | |
| TSTEGIYVSKILENG | 251 | Q6ZMN7 | |
| QRTDLGTSYLDIAKG | 16 | Q5JSJ4 | |
| YLLGSGTFIVKDLLQ | 131 | Q96PE3 | |
| YELGIISGALLQIKT | 56 | Q8TD20 | |
| RGSKGEVLYILDATN | 61 | Q9NQX1 | |
| GLGIIIYLLKQSAND | 1811 | Q92621 | |
| QKLSGKLYLVDLAGS | 221 | P33176 | |
| TIKYIGELTDLLNRG | 171 | A6NI15 | |
| KGNLESVSILLDYGA | 161 | Q9H765 | |
| STVDQVKDLYSGLIG | 881 | P00450 | |
| NLLSLGKREGIDQSY | 391 | O94952 | |
| KYSLLGGSNLLISNV | 286 | P43146 | |
| LLDSYVKIGEGSTGI | 406 | Q9NQU5 | |
| LYASLTSEKVQSLEG | 1761 | P46821 | |
| VKLISDAGYQGEITS | 176 | Q8IXH7 | |
| GDITLKGYNLSKSAL | 721 | Q3T906 | |
| LDLSKNAIGVYGILT | 986 | Q86W28 | |
| DLKQLLALKGSSYSG | 96 | Q4G0N4 | |
| LNLLTEYIEGGTLKD | 401 | P53671 | |
| YLAGSSIKGQVILTL | 31 | A6NEK1 | |
| LGELSGEKLLTTEYL | 611 | Q7Z3E5 | |
| ALYQTKLGELQTTAG | 391 | P12035 | |
| KSYDSLLTTLIGAGI | 1916 | Q8IYD8 | |
| GLSSSLGKELVFLQE | 351 | Q9NQG7 | |
| LGAGKTTLLNYILTE | 51 | Q8IUF1 | |
| LGAGKTTLLNYILTE | 51 | Q9BRT8 | |
| EGIKGSSLLNYVLGT | 396 | Q86SJ6 | |
| LDALKVTVGVDGTLY | 851 | P52789 | |
| SQDVASKGLGLVYEL | 1001 | Q5VYK3 | |
| GLDGNSADLRLVKTY | 1256 | Q9P2D6 | |
| LAKQTEIAYGTLDSG | 671 | P42263 | |
| LAKQTEIAYGTLDSG | 661 | P48058 | |
| YLGLATLITKAVDGE | 46 | Q8WY41 | |
| GSEYLKIDNLTGELS | 71 | O60245 | |
| VYLTKELGDTETVGL | 71 | O15018 | |
| TKSSYLNIVGLVGSI | 151 | P08237 | |
| DGLDSGKLYTLVLTD | 56 | P30086 | |
| ILGKSLRTDDINSGY | 826 | Q8IVL0 | |
| GVEGLTYLLTESSKL | 61 | Q86X83 | |
| SKSLETLLDHLGGLY | 981 | Q9ULK4 | |
| KTNVSTGLLLYLDDG | 56 | Q9Y4C0 | |
| ENLGKGEYQESLRSL | 921 | P48681 | |
| GIDLETSKYILANVG | 981 | Q7LBC6 | |
| NLTELGLQEIKTIGY | 986 | Q8IZD2 | |
| TKLDVGNIVLALYSG | 236 | Q01650 | |
| RLGEVGSTLYTKANL | 46 | Q8TAP4 | |
| GSKIYVDDGLISLQV | 171 | P14618 | |
| STLGGYLVTSFLLLK | 11 | Q8N9F7 | |
| NGTIVEKGSYSALLA | 836 | Q92887 | |
| KYGGKDLLLLNADSS | 521 | Q3SXY7 | |
| QLGRISYLLTDKTGT | 381 | O75110 | |
| ETKRLYVGGLSQDIS | 6 | Q76FK4 | |
| QLGKYAESILENGSS | 1701 | Q9Y4D8 | |
| TDSSLGRIAQYLKGL | 131 | Q8N1E6 | |
| SLAYIAQGLDGLKSL | 296 | Q8N1E6 | |
| DLEKLGLTGSQFLSV | 436 | Q9C091 | |
| KASGNVLRLETLYGT | 176 | Q7Z6J2 | |
| QEQSYLKSELGLGLG | 1076 | P28290 | |
| ELLQYGLKGTDLEAL | 601 | A2RRP1 | |
| LKVARDTDGTGNYLL | 601 | Q8TE96 | |
| LGGKYQGTILSIDDN | 456 | Q02413 | |
| YEGTGRSLSLKLIQQ | 416 | Q9H0A0 | |
| ISNIYLIKGSALRGE | 451 | Q02809 | |
| ESQGDGLAAISLYLK | 761 | Q9UG01 | |
| ALILDSLTGVDSGQY | 6071 | Q5VST9 | |
| SVASVYDGKLLIGTL | 331 | Q15165 | |
| EGNLYGTKIDSILEV | 411 | Q9NZW5 | |
| ATGETALYGNLILRK | 131 | A2VDF0 | |
| YSALLKNELLGAGIE | 91 | Q9UM11 | |
| ALDELGLSKYLESNG | 111 | P31327 | |
| NVLAKGYSGISLETL | 216 | P42357 | |
| GYSGISLETLKQVIE | 221 | P42357 | |
| QSLSALGFVYKLEGE | 436 | Q13325 | |
| QLQIEEAGGSYKLTL | 601 | Q9NZI5 | |
| QDLVVESLKSRYGLG | 11 | Q96M89 | |
| VGTNILTAVSYLKGL | 36 | O95500 | |
| GSEILKYLLEITDGN | 601 | Q53EP0 | |
| LLGQVLEGKNLVYSA | 101 | O75417 | |
| LQGLLSGVNKYSTVL | 6 | Q9NTQ9 | |
| LGAGKTTLLNYILTE | 51 | Q5JTY5 | |
| LGAGKTTLLNYILTE | 51 | Q4V339 | |
| TAAVESILYLGGNTK | 101 | Q96P44 | |
| CGNSLLGYLSEKLEL | 101 | Q7Z7H3 | |
| QRGEKSGIEILSLYD | 221 | Q9ULC5 | |
| DDGLLGTNVSYLKTK | 56 | Q5TB80 | |
| QLLDLGGVYDTEKNT | 1951 | Q0VDD8 | |
| KDTYLELGLVEAIGS | 306 | Q9H6B9 | |
| LGYKSSELEGDTITL | 361 | Q7KZI7 | |
| YIDKSQLTEDLGGTL | 206 | O15068 | |
| LRDLLSGVNKYSTGT | 6 | Q6PEY0 | |
| SYLGVIELIGEKETS | 361 | Q9BXX0 | |
| TYKGQDSTLGLSLNE | 146 | O00519 | |
| EYSLKNATGLGLIVT | 201 | Q08722 | |
| LILEGGYNLTSISES | 776 | Q9UBN7 | |
| GLVKRGSYIEETLSL | 111 | Q8N9H9 | |
| IFDGSLNSSLLLGKI | 1826 | Q9UGM3 | |
| LATGELGTLTNVYKA | 191 | Q9Y315 | |
| SKLLSISYAGAQLGT | 196 | Q9NRA2 | |
| YGEGDSLTLQQLKAL | 51 | Q15043 | |
| LLIKGGALSGTDTYQ | 26 | Q08AI6 | |
| GLLTFIANGKELSTY | 1516 | Q92736 | |
| LYGALTQGLQGLEKT | 101 | P0C7I6 | |
| LKDITLGTLGYGENE | 141 | Q8IZK6 | |
| SLEEVLRLGGTKQDY | 41 | Q03701 | |
| IDYLLSKNGSGNAII | 221 | Q96PD7 | |
| LLVNLRGADKSISYG | 81 | P59922 | |
| AGKSKLAGLLYTVLS | 286 | Q8NGR1 | |
| GIQLAKELGATYLEL | 161 | O94955 | |
| SYQLLKATELGLFGV | 601 | Q9Y5E3 | |
| VGIEGSLKGSTYNLL | 121 | O43482 | |
| LQLSTEGFITLTYKG | 1011 | P11717 | |
| KGQLYLLVTDQGFLT | 456 | Q8NBR6 | |
| DEGDIALLKTYGQST | 26 | P35998 | |
| STIDKATGILLYGLA | 46 | P47897 | |
| GDGLLYSASQDRTIK | 256 | Q9NVX2 | |
| ESLGELDKQLTTYLT | 1351 | P46939 | |
| LLEGETLSVQCSYKG | 31 | Q5T2D2 | |
| IDSLSLNGEFGYQKL | 326 | Q8TEQ0 | |
| LILNDGDISLTYGDS | 591 | Q92581 | |
| LDELKQSYLTLESGA | 5226 | Q8WXH0 | |
| LTADLTVKIGDYGLA | 261 | Q6ZMQ8 | |
| GETLKNLAVLSYEGG | 1261 | Q7Z494 | |
| LKGESSVELYSQVLL | 1416 | Q9P212 | |
| AIYSLGGKTLQDTLS | 331 | Q9NVX7 | |
| LEEKGVYVQASTLGS | 976 | O60841 | |
| LYGATLVQDGLALTD | 701 | Q9Y6C5 | |
| SLYLQLVETSLKGEI | 91 | Q8N165 | |
| QEAIITVKGISLGSY | 126 | Q96N28 | |
| KENLELNGSILSGGY | 546 | O43663 | |
| DIRKDLYTNTVLSGG | 951 | P0CG39 | |
| GSDDGVLAYKLLVQT | 876 | Q13635 | |
| KYEESNLGLLESSVG | 501 | Q86TU7 | |
| VLTDTEYKGLQLSLD | 331 | P81133 | |
| DVETKYGLLQVSEGL | 151 | Q6P3W7 | |
| ISEGLSNYSIIDKLV | 91 | P21583 | |
| SLLLVYSSLGGQKER | 21 | Q9BVH7 | |
| ILAKYLLETSGNLDG | 171 | P43490 | |
| LLETSGNLDGLEYKL | 176 | P43490 | |
| LDYILGALESGKNSG | 216 | Q5C9Z4 | |
| YIKSGGELDIVVTSN | 251 | Q96M27 | |
| DGNVRLYSILGTTLK | 466 | O75083 | |
| LSKTLQGTLLFGTYD | 86 | Q5H9E4 | |
| LTASLLIDGELYSGT | 176 | Q14563 | |
| GAYGATLSVLDQKIL | 1531 | O60287 | |
| ALEGVLSKYTNLLQG | 76 | Q9BXB5 | |
| SLLGKLVSYTNLTQG | 81 | Q9UP95 | |
| DSNYLLTGGQDKLLR | 111 | Q9Y3F4 | |
| KAYELSTLTGTQVLL | 171 | P11831 | |
| ANALGYSELGAIKSL | 1301 | P35498 | |
| SGTVYSGEEKLTELL | 146 | O95470 | |
| GLLKTEAESYEGLLA | 1316 | Q09428 | |
| TQELGKTIVYLDGSS | 336 | P21589 | |
| SIYEDKTALSLLGLG | 201 | Q9UPV0 | |
| ILINGDGTLTRKYSV | 241 | Q8TCG1 | |
| KTYLQGVELSGLSAA | 826 | O75153 | |
| NGIVILADYKGVSLS | 181 | Q9BTX7 | |
| GNYILSAGVDKTTII | 341 | O60907 | |
| SYIVQGLKSIGERDL | 281 | Q9UNS1 | |
| KSSLAAVQELGYSLG | 96 | Q9ULJ3 | |
| TGLSTLLGILYEDKE | 451 | Q9H1C4 | |
| SEGVVLLSYSGQKTE | 2811 | Q96T58 | |
| AGGKVLTSEDEYNLL | 121 | Q9BZQ8 | |
| TTAAVAGLLGLELYK | 856 | P41226 | |
| LLLKTANEGGSLLYE | 121 | Q96QD8 | |
| GGTLSSYIVKNIALD | 581 | Q9NW82 | |
| EDYGDTLAAIQGLLK | 1896 | Q13813 | |
| ANALGYSELGAIKSL | 1291 | Q99250 | |
| LLKYLSGSTLVESIN | 66 | A0A0B4J262 | |
| LGQTSISKGLNYLTI | 6 | Q99551 | |
| ANALGYSELGAIKSL | 1281 | Q9UQD0 | |
| GTALVTVGVLLYNKA | 356 | P0CK96 | |
| ALYKAGELTSNGRLT | 66 | P0DPF4 | |
| SSLDYGKDLTSVLIL | 661 | P11277 | |
| GLGVTYEQALAKDLS | 991 | P11137 | |
| DSTLKETLLNGVGYL | 1606 | O75643 | |
| QTLYSFSQLGGLEKD | 631 | Q9ULT0 | |
| DVLITLLSLGSNGYK | 321 | Q9HD40 | |
| DTGLLLSGGADNKLY | 396 | Q9GZL7 | |
| IGTKTGKLQLYDLAS | 471 | Q9UNX4 | |
| GKLQLYDLASGNLLE | 476 | Q9UNX4 | |
| GFIISNATYKEIGLL | 191 | P17948 | |
| DLQQGYALKSLTGLL | 4231 | Q5T4S7 | |
| KLTLGTYISLIAENS | 41 | P41732 | |
| ELALGINSGYSKRAL | 406 | O14939 | |
| LEKENYLTAGLTVGQ | 256 | Q99959 | |
| FVGDYSGQITLLKLE | 171 | Q8IWB7 | |
| KLGLRVTLDSDQVGY | 1361 | O95405 | |
| QGLQLLLKYFSGDTL | 61 | A0A0A6YYJ7 | |
| YSDLGEATLKIVGVT | 2736 | O75962 | |
| NLKLDRTYTGLQTLG | 306 | Q9ULM3 | |
| TAVGSILLYSTVKGE | 101 | Q15061 | |
| GIVGTLKVSLLLYDS | 61 | A0A1B0GTI8 | |
| KAYLGLSLKQLASGT | 746 | Q96L42 | |
| LSKGLYGINEDIFLS | 276 | Q6ZMR3 | |
| LVLGSANVDESLLGY | 511 | Q6IA69 |